Cysteamine alters redox state, HIF-1α transcriptional interactions and reduces duodenal mucosal oxygenation: Novel insight into the mechanisms of duodenal ulceration

Biochemical and Biophysical Research Communications

Volumn 317, Issue 1, 2004, Pages 121-127

  Khomenko, Tetyana ^a   Deng, Xiaoming ^a   Sandor, Zsuzsanna ^a   Tarnawski, Andrzej S ^a   Szabo, Sandor ^a  

^a NONE

Author keywords

Cysteamine; Egr 1; HIF 1 ; Redox state; Tissue oxygenation; Transcription factors

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MERCAPTAMINE; REDUCING AGENT; STAT4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR L III BP; TRANSCRIPTION FACTOR MRE; TRANSCRIPTION FACTOR NF E1; TRANSCRIPTION FACTOR NF E2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DUODENUM MUCOSA; DUODENUM ULCER; FEMALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXYGEN TISSUE LEVEL; OXYGENATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; CELL NUCLEUS; CYSTEAMINE; CYTOPLASM; DNA; DNA-BINDING PROTEINS; DUODENAL ULCER; DUODENUM; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTESTINAL MUCOSA; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 1642463497     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.017     Document Type: Article

References (35)

1. Selye H., Szabo S. Experimental model for production of perforating duodenal ulcers by cysteamine in the rat. Nature. 244:1973;458-459.
2. Szabo S. Animal model of human disease. Duodenal ulcer disease. Animal model: cysteamine-induced acute and chronic ulcer in the rat. Am. J. Pathol. 93:1978;273-276.
3. Szabo S., Pihan G. Development and significance of cysteamine and propionitrile models of duodenal ulcer. Chronobiol. Int. 4:1987;31-42.
4. Biaglow J.E., Issels R.W., Gerweck L.E., Varnes M.E., Jacobson B., Mitchell J.B., Russo A. Factors influencing the oxidation of cysteamine and other thiols: implications for hyperthermic sensitization and radiation protection. Radiat. Res. 100:1984;298-312.
5. Capozzi G., Modena G. Oxidation of thiols. Patai S. The Chemistry of the Thiol Group. 1974;785-840 John Wiley, London.
6. Tahsildar H.I., Biaglow J.E., Kligerman M.M., Varnes M.E. Factors influencing the oxidation of the radioprotector WR-1065. Radiat. Res. 113:1998;243-251.
7. Halliwell B., Gutteridge J.M.C. Free Radical in Biology and Medicine. 1989;Clarendon Press, Oxford.
8. Jeitner T.M., Lawrence D.A. Mechanisms for the cytotoxicity of cysteamine. Toxicol. Sci. 63:2001;57-64.
9. Held K.D., Biaglow J.E. Mechanisms for the oxygen radical-mediated toxicity of various thiol-containing compounds in cultured mammalian cells. Radiat. Res. 139:1994;15-23.
10. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54:1985;237-271.
11. Szabo S., Vincze A., Sandor Z., Jadus M., Gombos Z., Pedram A., Levin E., Hagar J., Iaquinto G. Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF. Dig. Dis. Sci. 43:1998;40S-45S.
12. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 322:1988;411-415.
13. Tanaka H., Takeuchi K., Okabe S., Murakami M. Pathogenesis of the earliest epithelial cell damage induced by mepirizole and cysteamine in the rat duodenum. Jpn. J. Pharmacol. 51:1989;509-519.
14. Khomenko T., Deng X.M., Jadus M.R., Szabo S. Effect of cysteamine on redox-sensitive thiol-containing proteins in the duodenal mucosa. Biochem. Biophys. Res. Commun. 309:2003;910-916.
15. Khomenko T., Szabo S., Deng X.M., Matsumoto H., Ishikawa H. Aggravation of experimental duodenal ulcers by the suppression of transcription factor Egr-1 synthesis with egr-1 antisense. Gastroenterology. 120:2001;A144.
16. Deng X.M., Szabo S., Khomenko T., Yoshida M., Florsheim W.H. Changes in endogenous vascular endothelial growth factor (VEGF) in duodenal ulceration. Gastroenterology. 116:1999;A601.
17. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:1992;5447-5454.
18. Wang G.L., Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:1993;21513-21518.
19. 2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.
20. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1995;1230-1237.
21. Salceda S., Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272:1997;22642-22647.
22. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:1996;4604-4613.
23. Bunn H.F., Gu J., Huang L.E., Park J.W., Zhu H. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J. Exp. Biol. 201:1998;1197-1201.
24. Nor J.E., Christensen J., Mooney D.J., Polverini P.J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am. J. Pathol. 154:1999;375-384.
25. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271:1996;32253-32259.
26. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J. Biol. Chem. 276:2001;12645-12653.
27. Kimura H., Weisz A., Ogura T., Hitomi Y., Kurashima Y., Hashimoto K., D'Acquisto F., Makuuchi M., Esumi H. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 276:2001;2292-2298.
28. Bunn H.F., Poyton R.O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76:1996;839-885.
29. Semenza G.L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J. Clin. Invest. 106:2000;809-812.
30. Elson D.A., Thurston G., Huang L.E., Ginzinger D.G., McDonald D.M., Johnson R.S., Arbeit J.M. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 15:2001;2520-2532.
31. Szabo I.L., Kawanaka H., Jones M.K., Pai R., Soreghan B.A., Baatar D., Husain S.S., Tarnawski A.S. Activation of hypoxia inducible factor-1alpha in gastric mucosa in response to ethanol injury: a trigger for angiogenesis? Life Sci. 69:2001;3035-3044.
32. Baatar D., Jones M.K., Tsugawa K., Pai R., Moon W.S., Koh G.Y., Kim I., Kitano S., Tarnawski A.S. Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing. Am. J. Pathol. 161:2002;1449-1457.
33. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F., Addeo R., Makuuchi M., Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood. 95:2000;189-197.
34. Laderoute K.R., Calaoagan J.M., Gustafson-Brown C., Knapp A.M., Li G.C., Mendonca H.L., Ryan H.E., Wang Z., Johnson R.S. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol. Cell. Biol. 22:2002;2515-2523.
35. Welsh S.J., Bellamy W.T., Briehl M.M., Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1 alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62:2002;5089-5095.